Eli Lilly Launches Alzheimer's Therapy Donanemab in India for ₹91,688 per Vial
Eli Lilly brings monthly Alzheimer's therapy donanemab to India at ₹91,688 per vial
The Economic Times
Image: The Economic Times
Eli Lilly has introduced Lormalzi (donanemab), a monthly therapy for early symptomatic Alzheimer's disease, in India at a price of ₹91,688 per 350 mg vial. The treatment is expected to be available through hospitals and pharmacies, with a finite treatment period of up to 18 months.
- 01Lormalzi (donanemab) targets amyloid plaques in Alzheimer's patients.
- 02The therapy is priced at ₹91,688 per vial and is administered monthly.
- 03Treatment duration can last up to 18 months.
- 04Eli Lilly aims to enhance access through an alternative access program.
- 05The launch aligns with Eli Lilly's focus on neurodegenerative diseases.
Advertisement
In-Article Ad
Eli Lilly and Company has launched Lormalzi (donanemab), a new treatment for early symptomatic Alzheimer's disease, in India. Priced at ₹91,688 for a 350 mg vial, the therapy is administered as an intravenous infusion once every four weeks, with a treatment duration of up to 18 months. Winselow Tucker, president and general manager of Eli Lilly India, emphasized that Alzheimer's disease is a crucial part of the company's long-term innovation strategy, which also includes obesity and metabolic therapies. To improve patient access, Eli Lilly plans to implement an alternative access program, ensuring that more patients can benefit from this new therapy. The drug is set to be available this month through hospitals and pharmacies.
Advertisement
In-Article Ad
The introduction of Lormalzi may provide new treatment options for Alzheimer's patients in India, potentially improving their quality of life.
Advertisement
In-Article Ad
Reader Poll
Do you think new Alzheimer's therapies should be prioritized in India?
Connecting to poll...
More about Eli Lilly and Company
L'action Eli Lilly en hausse grâce à des résultats d'essais cliniques prometteurs
Investing French • May 14, 2026
भारत में लॉन्च हुई अल्जाइमर की नई दवा Lormalzi, क्या लौटाएगी याददाश्त?
Ndtv • May 13, 2026
Eli Lilly Introduces Alzheimer's Treatment Lormalzi in India at ₹91,688 per Vial
Ndtv • May 13, 2026
Read the original article
Visit the source for the complete story.